Category: Editorials

Milwaukee secures line of credit for its 2020 Democratic Convention bid

Milwaukee secures line of credit for its 2020 Democratic Convention bid

Great article from the Milwaukee Journal Sentinel. Milwaukee secures line of credit for its 2020 Democratic Convention bid Mary Spicuzza Organizers of Milwaukee’s bid for the 2020 Democratic National Convention have lined up a third-party line of credit, clearing the last major hurdle in the city’s quest to host the convention, Mayor Tom Barrett said Wednesday. “That issue has…

Read More Read More

Retaliatory Tariffs on Cranberry Industry

Retaliatory Tariffs on Cranberry Industry

Due to President Trump’s decision to impose tariffs on steel and aluminum imports, retaliatory tariffs have been imposed on many U.S. goods. Canada, Mexico, China, and the European Union are among those who have instituted retaliatory tariffs on U.S. imports such as cranberries and cranberry products. President Trump claims that the specific measures are meant…

Read More Read More

Exact Sciences CEO Says Company Has “Attractive Long-Term Opportunity.”

Exact Sciences CEO Says Company Has “Attractive Long-Term Opportunity.”

Barron’s (5/2, Bary, 948K) reports that according to Exact Sciences CEO Kevin Conroy, there continues to be “big growth from the company’s colon-cancer test,” Cologuard. According to Barron’s, Exact Sciences “has successfully secured reimbursement from Medicare and most commercial insurers for the self-administered test.” Conroy says that Cologuard “could ultimately deliver revenue of $5 to $6…

Read More Read More

Do you need a lobbyist?

Do you need a lobbyist?

Whether to hire a lobbyist or not? This question always presents a difficult decision because one doesn’t know the outcome. Wall Street has developed an index fund that attempts to resolve the dilemma (https://www.barrons.com/articles/lobbying-index-beats-the-market-1524863200). “About 10-years-ago, Srategas (https://www.strategasrp.com/OurFirm) devised a ‘lobbying index’ of companies that get the most bang for their lobbying buck, including interaction…

Read More Read More

Exela CEO Dr. Phanesh Koneru Interviews President George W. Bush at Becker’s Healthcare Conference

Exela CEO Dr. Phanesh Koneru Interviews President George W. Bush at Becker’s Healthcare Conference

April 13, 2018 Chicago, Illinois On Friday, April 13, 2018, Phanesh Koneru, PhD, LLM, President and CEO of Exela Pharma Sciences interviewed the Honorable George W. Bush, 43rd President of the United States of America at the 9th Annual Becker’s Hospital Review conference in front of 4,000 attendees. The conference is attended by the nation’s…

Read More Read More

MMSD Named Top 25 Global Water Leader

MMSD Named Top 25 Global Water Leader

Broydrick & Associates is proud to share Mr. Kevin Shafer’s, Executive Director, Milwaukee Metropolitan Sewer District (MMSD), most recent achievement: being named a Water & Wastewater International Top 25 Global Water Leader. WWI prides itself on spreading reliable and informative news to a global water audience.  Their Top 25 Global Water Leaders initiative has grown in popularity over the past…

Read More Read More

WISH Mentioned in Politico

WISH Mentioned in Politico

We wanted to share the recent Politico mention of our client Washington Intern Student Housing (WISH). We’re so proud to work with our friend, Jacqueline Lewis, who provides interns with affordable and accessible housing–opening them to a world of opportunity here in the heart of Washington D.C.. OUT AND ABOUT IN D.C. — SPOTTED last night at…

Read More Read More

C-Suite Wednesday — Senate Restores USDA B&I Lending Authority

C-Suite Wednesday — Senate Restores USDA B&I Lending Authority

From Coleman Report Interview On June 30, I reported the House appropriated funding for rural Main Street that had been cut in the FY18 Budget. Last week, the Senate followed the House lead to restore funding to the USDA B&I Loan Program. I interviewed Bill Broydrick about the USDA Business & Industry lending program. Coleman…

Read More Read More

Exact Sciences on CNBC

Exact Sciences on CNBC

Our client Exact Sciences has had enormous success with their non-invasive colon cancer test. It is a test that widely adopted, has the real possibility of virtually eradicating colon cancer. Last Friday night CEO Kevin Conroy appeared on Jim Cramers CNBC show. Take a look.